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Introduction: One common cause of disability in modern society is low back pain. The 
main reason for this pain is the degeneration of the intervertebral disc (IVD), 
particular of the nucleus pulposus (NP). For an early degeneration stage cell-based 
therapy would be a minimal invasive method of treatment. Therefore, adequate cells 
are needed. As the usage of NP cells is limited because of their insufficient amount 
or vitality, a promising alternative is the application of human mesenchymal stem 
cells (hMSCs). Objective: To investigate the potential of various growth factors to 
induce the differentiation of hMSCs into NP cells and thereby to obtain an alternative 
cell source for the treatment of IVD degeneration. Methods: hMSC-TERT were 
cultivated three-dimensionally in a hydrogel for 21 days to form NP cells. Cell survival 
and proliferation were determined using SybrGreen/propidium iodide double staining 
and the WST-test. To investigate the ability of several growth factors to differentiate 
hMSCs into NP cells, fluorescence immunostaining of NP-specific marker proteins 
(e.g. chondroadherin (CHAD) and the recently discovered cytokeratin 19 [1]) was 
performed. Results: Following the procedure described above, cells are able to 
maintain their viability and proliferation capacity throughout the cultivation time. By 
using a previously established immunofluorescence protocol, we could indicate the 
ability of three different growth factors to differentiate hMSCs into NP-like cells. 
Conclusion: The expression of several marker proteins in all differentiation 
experiments indicates the ability of IGF-1, FGF-2 and PDGF-BB to differentiate 
hMSCs into NP-like cells apart from the usually applied TGF-β3. Furthermore, our 
findings preclude the application of Cytokeratin 19 as a specific marker protein for NP 
cells [1]. Further experiments have to be done to find real specific NP marker proteins 
to indisputable verify the differentiation of hMSCs into NP cells. If so, application of 
the mentioned three growth factors would possibly be an option to obtain sufficient 
NP cells for minimal invasive IVD regeneration. 
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INTRODUCTION 
 
The degeneration of the intervertebral disc (IVD), particular of the nucleus pulposus 
(NP), is one reason for low back pain, which is a common disease in Western 
societies. The major reason for this pain is the pressing of the NP from the inside of 
the IVD towards the anulus fibrosus on the outside of the disc and finally towards the 
spinal cord. IVD degeneration progresses in stages, starting with an increasing 
damage of the NP which leads to the mentioned bulging (IVD protrusion). As a 
consequence, the anulus fibrosus ruptures and thus, the nucleus pulposus leaks into 
the spinal canal (IVD prolaps). In the stage of IVD protrusion where the anulus 
fibrosus is (almost) intact, one possible method of treatment is a cell-based therapy 
of the NP. Therefore, adequate cells e.g. NP cells are needed. One major problem in 
using these cells is their insufficient amount and vitality resulting from the progressing 
IVD degeneration. Moreover, an auxiliary operation is necessary to extract 
autologous NP cells. In contrast to NP cells, vital human mesenchymal stem cells 
(hMSC) are available in sufficient amount in tissue. Besides the immune privilege of 
the avascular structured IVD itself, hMSCs avoid allorecognition and, therefore, 
circumvent immune response [2, 3]. For these reasons our workgroup focuses on the 
application of hMSCs for IVD regeneration.  
hMSCs must be differentiated into NP cells prior to implementation into the body. A 
three-dimensional environment is required as NP cells dedifferentiate when growing 
in a monolayer [4, 5]. Currently, NP cells and the differentiation process are poorly 
understood. This results from the presumption that NP cells are considered to be 
chondrocytes. This seems to be not correct since the gene expression profile of IVD 
cells significantly differs from that of chondrocytes [6]. Our workgroup focuses on the 
distinction between NP cells (e.g. to NP cells differentiated hMSCs), undifferentiated 
stem cells and chondrocytes by using fluorescence immunostaining. Based on the 
results from Steck et al. [6] cartilage oligomeric matrix protein (COMP), 
chondroadherin (CHAD) and collagen II were chosen as marker proteins to 
discriminate between undifferentiated hMSCs, chondrocytes and IVD cells in general. 
Additionally, cytokeratin 19 (Krt 19) was selected as a putative NP-specific marker 
protein because its mRNA expression has been shown to be significantly higher in 
NP cells compared to anulus fibrosus and articular cartilage cells [1]. 
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Apart from the three-dimensional environment, various stimuli are essential for the 
differentiation of stem cells. In vivo, growth factors and the extracellular matrix form 
cellular niches to regulate the proliferation and differentiation of the embedded cells 
[7]. Therefore, our workgroup started with the investigation of growth factors 
regarding their applicability to differentiate hMSCs into NP cells. Usually, 
transforming growth factor-β3 (TGF-β3) is used to induce the differentiation of 
mesenchymal stem cells into NP-like cells [6, 8-10]. Unfortunately, hMSCs with TGF-
β3 induced differentiation showed expression of genes typically for hypertrophic 
chondrocytes or bone [6]. For subsequent therapeutical use of the differentiated cells 
for IVD regeneration, only original NP cells (e.g. to NP cells differentiated stem cells) 
can be used. Therefore, it is necessary to find alternate growth factors which 
stimulate stem cells only into the lineage of NP cells. Pratsinis and Kletsas [11] 
described insulin-like growth factor 1 (IGF-1), fibroblast growth factor 2 (FGF-2) and 
platelet-derived growth factor BB (PDGF-BB) as growth factors which are typically 
expressed in the IVD of various species. These three growth factors have been 
shown to induce the proliferation of NP and AF cells [11]. The aim of our working 
group was to find out whether these three growth factors have additional 
differentiation inducing capabilities. If so, their application instead of TGF-β3 might 
open up a possible way to obtain sufficient NP cells for IVD regeneration. 
 
MATERIAL AND METHODS 
 
Cell cultivation  
Human mesenchymal stem cells with reverse telomerase transcriptase (hMSC-
TERT) were obtained from CellMed, Alzenau, Germany. This genetic modification 
allows an increasing generation number because the telomeres aren`t shortened 
during mitosis. For preliminary cell expansion, Eagle´s minimal essential medium 
(EMEM; PAA, Pasching, Austria) supplemented with 10% fetal bovine serum (FBS; 
PAA), 100 U/ml Penicillin and 100 µg/ml Streptomycin (both Biochrom, Berlin, 
Germany) was used. The cells were cultivated in a humidified incubator at 37 °C with 
5% CO2. 
Human nucleus pulposus cells (HNPC) were obtained from ScienCell (Carlsbad, 
USA) and cultured in nucleus pulposus cell medium (ScienCell) with supplements 
provided by the manufacturer. The cells were cultivated in a humidified incubator at 
37 °C with 5% CO2. 
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Cell differentiation 
Dulbecco´s modified Eagle´s medium (DMEM-LG; Biochrom) containing 3.7 mg/ml 
sodium hydrogen carbonate (Carl Roth, Karlsruhe, Germany), 100 U/ml Penicillin and 
100 µg/ml Streptomycin (both Biochrom), 1x Insulin-Transferrin-Selenium-X 
(Invitrogen, Germany), 0.5 mg/ml bovine serum albumin (Carl Roth), 1.25 mg/ml 
human serum albumin (Sigma-Aldrich, Steinheim, Germany), 4.7 µg/ml linolic acid 
(AppliChem, Darmstadt, Germany), 0.1 µM dexamethasone (Sigma-Aldrich), 0.1 mM 
2-phospho-L-ascorbic acid trisodium salt (Sigma-Aldrich) and 0.28 nM growth factor 
was used for differentiation of hMSC-TERT into NP cells. Depending on the 
experiment, human Insulin-like Growth Factor-1 (IGF-1; Sigma-Aldrich), human 
Fibroblast Growth Factor-basic (FGF-2; Biochrom), human Platelet Derived Growth 
Factor-BB (PDGF-BB; Biochrom) or Transforming Growth Factor-β3 (TGF-ß3; 
Biochrom), were added to the differentiation media. 
 
Cell differentiation by using cell pellets 
To evaluate the differentiation and immunostaining protocol, preliminary 
differentiation was done in form of pellet cultures with the known differentiation 
inducing growth factor TGF-β3. Therefore, 2·105 hMSC-TERT were washed with 
2.5 ml differentiation medium without TGF-β3, centrifuged (5 min at 150 g), 
resuspended in differentiation medium which included TGF-β3 and once again 
centrifuged (5 min at 150 g). Medium was exchanged every 2-3 days. On cultivation 
days 1, 4, 7, 11, 16 and 21, cell pellets were fixed with 4% paraformaldehyde for 20 
min at room temperature and stored in phosphate buffered saline (PBS; Biochrom) at 
4°C until immunostaining. 
 
Cell differentiation in hydrogels 
Subsequent differentiation of hMSC-TERT was done in hydrogels of 2% low gelling-
point agarose (Sigma-Aldrich) for 21 days to form NP cells. 2.4·105 cells per 600 µl 
hydrogel were used. Differentiation was done in 12well-plates at 37 °C and 5% CO2 
with media exchange every 3-4 days. By addition of IGF-1, FGF-2 or PDGF-BB to the 
differentiation medium (without TGF-β3), the ability of these growth factors to support 
the differentiation of hMSCs into NP cells, was tested. On cultivation days 1, 4, 7, 11, 
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15 and 21, the hydrogels were fixed with 4% paraformaldehyde (in PBS; Biochrom) 
for 20 min at room temperature and stored in PBS at 4°C until immunostaining. 
  
Measurement of cell viability 
Cell survival was estimated by SybrGreen (1/25 in dimethyl sulfoxide; Sigma-Aldrich) 
and propidium iodide (5 g/l in PBS; Sigma-Aldrich) staining as described in [12]. Live-
dead-ratio of cells was analyzed using fluorescence microscopy. 
 
Measurement of cell proliferation 
Cell proliferation reagent WST-1 (Roche Diagnostics, Mannheim, Germany) was 
used for quantification of the metabolic activity (cell respiration) of the cells within the 
hydrogels at different time points during the cultivation. On days 0, 3, 6, 10, 14 and 
20, 20 µl of WST-1 were added to 1,980 µl of fresh differentiation medium and 
incubated in a humidified incubator at 37 °C for 19 h and 45 min. Medium with WST-
1 alone served as negative control. Absorbance was measured at 450 nm with a 
microplate reader (Synergy HT, BioTek, Bad Friedrichshall, Germany). Information 
about cell proliferation was obtained by comparison of the absorbance at different 
time points.  
 
Immunostaining of specific marker proteins 
NP-specific marker proteins (cartilage oligomeric matrix protein (COMP), 
chondroadherin (CHAD), collagen II and cytokeratin 19 (Krt 19)) were stained by 
immunofluorescence in hydrogels, fixed on cultivation day 1, 4, 7, 11, 15 or 21. As 
blocking solution, 0.01 M PBS (pH 7.2; Biochrom) with 2% serum (species same as 
secondary antibody; PAA), 1% BSA (Carl Roth), 0.1% Triton X-100 (Carl Roth) and 
0.05% Tween 20 (Carl Roth) was used. After 1 hour incubation at room temperature, 
the blocking solution was discarded and 2 µg/ml primary antibodies (mouse anti-
human COMP: Kamiya Biomedical Company, MC-810; mouse anti-human CHAD: 
Abnova, H00001101-M01; rabbit anti-human collagen II: Biologo, CO20211-0.1; 
mouse anti-human cytokeratin 19: AbD Serotec, 5552-9009) were added in primary 
antibody dilution buffer (0.01 M PBS, 1% BSA, 0.5% Triton X-100, pH 7.2). After 1 
hour incubation at room temperature, the hydrogels were washed three times with 
washing solution (0.01 M PBS, 0.05% Tween 20, pH 7.2). Thereafter, secondary 
antibodies (6 µg/ml sheep anti-rabbit FITC: Yo Proteins AB, 173; 10 µg/ml goat anti-
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mouse TR: Fitzgerald Industries International, 43C-CB5102) were added. After 30 
minutes of incubation at room temperature and following three wash steps, the 
hydrogels were counterstained with DAPI (AppliChem, Germany) for 20 minutes at 
room temperature. After three concluding washing steps, the hydrogels were ready 
for analysis via fluorescence microscopy. 
 
Fluorescence microscopy 
Immunostained or SybrGreen/propidium iodide stained hydrogels were transferred 
into a multiwell plate with glass bottom and kept in PBS to prevent dehydration and 
analyzed via a fluorescence wide-field microscope (DMI6000, Leica Microsystems, 
Wetzlar, Germany) using filter cubes A4 (ex.: BP 360/40, em.: BP 470/40), L5 (ex.: 
BP 480/40, em.: BP 527/30) and N3 (ex.: BP 546/12, em.: BP 600/40) and LAS AF 
Software (Leica Microsystems). 
 
RESULTS 
 
Using immunofluorescence staining we could detect cartilage oligomeric matrix 
protein (COMP), chondroadherin (CHAD) and collagen II in hMSC-TERT cell pellets 
at specific time points during the 21 days of differentiation with TGF-β3 (Fig. 1).  
Conventional pellet cultivation contrasts with the low cell density of NP cells in vivo. 
Therefore, we changed to differentiation within agarose hydrogels. Using SybrGreen/ 
propidium iodide staining we investigated the survival of hMSC-TERT after the whole 
differentiation period at different cell densities in order to obtain the most suitable. 
Independent of the density, cells remain viable throughout the whole cultivation time 
(data not shown). Because of the good live-dead-ratio of cells we selected 2.4·105 
cells per hydrogel (Fig. 2) for experiments to evaluate the influence of growth factors 
on differentiation of hMSC-TERT into NP cells.  
Within these hydrogels, cell proliferation throughout the 21 days of differentiation was 
quantified using the WST-test for measurement of cell respiration (more precisely the 
activities of several dehydrogenase) (Fig. 3). All four growth factor approaches 
showed different behavior in cell proliferation during the 21 days of differentiation. In 
contrast to TGF-β3 and IGF-1, which acted similarly with highest cell respiration 
activity on day 7 and 15, FGF-2 led to highest cell respiration activity on day 7 and 
showed a subsequent decrease. With the use of PDGF-BB, highest cell respiration 
activity was detected over a time period from day 7 to day 15. 
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Based on the results from the staining in cell pellets (Fig.1), adequate time points 
during differentiation were chosen for fluorescence immunostaining of the different 
marker proteins (COMP, CHAD and collagen II). Fluorescence immunostaining of the 
hydrogels revealed high expression of collagen II but low expressions of COMP and 
CHAD within all four differentiation approaches (Fig. 4). Expression of cytokeratin 19 
(Krt 19) was detected throughout the whole differentiation time with comparatively 
high expression in the approach with IGF-1 (Fig. 5). Actually, Krt 19 expression 
decreased with increasing differentiation time (Fig. 5). Nevertheless, human nucleus 
pulposus cells cultivated for 23 days in a hydrogel showed expression of Krt 19 as 
well (Fig. 6). 
 
DISCUSSION 
 
In this study, we used hMSC-TERT instead of primary hMSCs not only to achieve 
increased generation numbers but also to obtain a standardized cell line without the 
differences usually observed when various donor sources are used. 
hMSC-TERT remain viable throughout the whole cultivation time when cultured in 
hydrogels of 2% agarose in differentiation medium which included TGF-β3. Because 
of the good live-dead-ratio of cells, 2.4·105 cells per 600 µl hydrogel were chosen for 
the investigations concerning the putative differentiation potential of IGF-1, FGF-2 
and PDGF-BB. Our working group assumed that hMSC-TERT cultivated in 
differentiation inducing media with IGF-1, FGF-2 and PDGF-BB will survive, too. A 
density of 2.4·105 cells per 600 µl hydrogel conforms to a cell density of 4·105 cells 
/cm³. As shown in this study, for this cell concentration, 0.28 nM of the three tested 
growth factors are able to stimulate the differentiation of human mesenchymal stem 
cells into NP-like cells. In vivo, NP cells exist in concentrations of about 4·106 cells 
/cm³ [13]. In combination, 2.8 nM of the mentioned growth factors would be able to 
induce differentiation of hMSC-TERT into NP-like cells when cultured under in vivo-
like conditions. As cell-cell-interactions by means of cellular crosstalk may also 
contribute to differentiation processes, the experiments described here have to be 
repeated with the natural NP cell-concentration.  
This study shows that all three growth factors (IGF-1, FGF-2 and PDGF-BB) can 
stimulate the differentiation of hMSC-TERT into the lineage of NP cells. According to 
our current knowledge, no investigations have been performed yet which show the 
differentiation of hMSCs into NP-like cells by means of growth factors (except for 
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TGF-β3 with the resulting drawbacks mentioned in the introduction). However, 
regarding osteogenic and chondrogenic differentiation, FGF-2 has been shown to 
increase the differentiation potentials of hMSCs when added to the culture media 
before the differentiation was started by changing to specific differentiation-inducing 
medium [14]. It has been shown that the applied growth factors can stimulate the 
proliferation of NP cells. Pratsinis and Kletsas determined the concentrations of 
IGF-1, FGF-2 and PDGF-BB, which had a maximal stimulatory effect on DNA 
synthesis as 100 ng/ml (13,08 nM), 5 ng/ml (0,30 nM) and 10 ng/ml (0,41 nM) [11]. 
Zhang et al. described 100 ng/ml IGF-1 to provoke maximal proliferation of human 
NP cells in a monolayer as well [15]. It should be mentioned that the experimental 
conditions of these studies differed from those of our study. Pratsinis and Kletsas 
used bovine coccygeal NP cells and Zhang et al. human NP cells which were 
cultured in a monolayer [11, 15], whereas our group used differentiated hMSCs which 
were cultured three dimensionally in a hydrogel. It is still difficult to compare these 
studies not only because of the different cell types but also because of the different 
cultivation settings (monolayer vs. 3D). Especially for NP cells, it is well known that 
the behavior of cells differs when cultured in a monolayer instead of a three 
dimensional cultivation [16]. Nevertheless, our investigations show similar results 
compared to the work of Pratsinis and Klestas [11] because a maximal proliferation 
stimulation effect could be detected with PDGF-BB in both studies. 
In our study with IGF-1, FGF-2 and PDGF-BB, a connection between the proliferation 
profile and the expression profile of the differentiation markers could not be seen. 
Surprisingly, almost no cell proliferation could be detected on the last cultivation day 
even though live-dead-staining revealed almost 95% cell viability after 21 days of 
cultivation. One possible explanation could be some limitations within the hydrogel 
between the cultivation days 15 and 21 which led to cell starvation but not to cell 
dead. Since live-dead-staining was exemplary performed with TGF-β3 as 
differentiation inducing growth factor, these measurements have to be also done with 
IGF-1, FGF-2 and PDGF-BB. A negative effect of the used agarose on cell 
proliferation is unlikely because vital nucleus pulposus cells were successfully 
cultured within agarose hydrogels [17]. Concerning chondrocytes, agarose could not 
only be used for cell survival but also for redifferentiation of monolayer cultured cells 
[18]. Human bone-marrow derived mesenchymal stem cells cultured with 
chondrogenesis inducing media in 2% agarose hydrogels survived and expressed 
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chondrogenic markers, too [19]. Huang et al. showed a clear relationship between 
the cell seeding density within the agarose hydrogel and the expression of 
chondrogenic markers [19]. As highest gene expression could be detected with 9·106 
cells /ml [19], it is likely that the density applied in the present study was too low for 
optimal cell growth. As mentioned earlier, the growth factor experiments presented in 
this study will be repeated with the natural occurring NP cell density (4·106 cells /ml) 
[13], which will be closer to the cell density from Huang et al. [19]. Therefore, we 
expect better proliferation and higher expression of the marker proteins within the 
following study. 
Additional experiments could be the analysis of different concentrations or 
combinations of growth factors to investigate synergistic effects which are known 
from other cell types as well. 
Expressions of collagen II, COMP, CHAD and Krt 19 within the pellets (no Krt 19 
staining implemented) and hydrogels proved the applicability of the established 
fluorescence immunostaining method. The high expression of collagen II for all 
growth factors investigated was expected as this is the predominant matrix 
component in the nucleus pulposus [20]. In proportion to the expression of collagen 
II, few amounts of COMP and CHAD were detected. This correlates with the findings 
of Steck et al. [6], who assessed the gene expression levels of IVD tissue, cartilage 
and TGF-β3 induced hMSCs. Thereby, it has to be noticed that articular cartilage and 
anulus fibrosus cells are specified by a significant higher expression of COMP 
compared to NP cells [1]. Thus, the detected little amount in the study of our working 
group indicates that the hMSC-TERT cells were differentiated into the lineage of NP-
like cells and not into chondrocytes or AF cells. To obtain more indications that 
hMSC-TERT were differentiated into NP cells we used cytokeratin 19 (Krt 19) as a 
putative new NP marker protein. In 2009, Rutges et al. compared the mRNA 
expression profiles of NP cells, anulus fibrosus cells and articular cartilage cells [1]. 
They found Krt 19 as a putative NP specific marker protein because its mRNA 
expression has been shown to be significantly higher in NP cells compared to anulus 
fibrosus and articular cartilage cells [1].  The mRNA expression of Krt 19 was 
ascertained to be 5 units lower in log-scale compared to mRNA expression of 
cartilage oligomeric matrix protein (COMP) in NP cells [1]. In contrast to these 
findings, in our study, expression of Krt 19 was higher than expression of COMP. 
Furthermore, in the present study, Krt 19 was expressed in all four differentiation 
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approaches from the outset of the immunostaining on day 1. Apart from the fact that 
further experiments have to be done, it is unlikely that first expression of Krt 19 in 
differentiation into NP cells occurs at day one of cultivation in the medium inducing 
differentiation. So, Krt 19 seems to be expressed in mesenchymal stem cells, too. 
Consequently, Krt 19 could not be used for characterizing NP cells if comparisons 
with hMSCs are required. Nevertheless, expression of Krt 19 was highest in 
hydrogels cultivated with IGF-1, which could indicate that the differentiation inducing 
capacity of IGF-1 is higher than the capacities of FGF-2, PDGF-BB and even higher 
than the capacity of TGF-β3.  
Further experiments will be done to find real specific NP marker proteins for the 
discrimination between NP cells, chondrocytes and mesenchymal stem cells.  
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Legends 
 
Figure 1: Immunostaining of NP-specific marker proteins in cell pellets after 
differentiation with TGF-β3 (0.28 nM). As cartilage oligomeric matrix protein (COMP), 
chondroadherin (CHAD) and collagen II expression started at different time points 
during differentiation, representative pictures from different fixation days plus 
positive/negative control were assorted. A: Expression of COMP on cultivation days 
0, 4, 7 and 21. B: Expression of CHAD on cultivation days 0, 11, 16 and 21. 
C: Expression of collagen II on cultivation days 0, 11, 16 and 21. Magnification: 100x.  
 
Figure 2: Cell survival in the hydrogel (600 µl) after 21 days of differentiation with 
TGF-β3 (0.28 nM). A: Living cells (green in overlay). B: Dead cells (red in overlay). 
C: Overlay. Magnification: 100x.  
 
Figure 3: Determination of cell proliferation in dependency on the added growth 
factor by incubation with WST-1 reagent and measuring the resultant absorbance at 
450 nm. Striped: TGF-β3. White: IGF-1. Grey: FGF-2. Black: PDGF-BB. Bars display 
mean values (n=9) with standard deviation. 
 
Figure 4.1: Influence of growth factors on the differentiation by immunostaining of 
NP-specific marker proteins on days 1, 4 and 7. A: cartilage oligomeric matrix protein 
(COMP; green in overlay). B: DAPI (blue in overlay). C: Overlay. Magnification: 400x 
 
Figure 4.2: Influence of growth factors on the differentiation by immunostaining of 
NP-specific marker proteins on days 11 and 21. A: chondroadherin (CHAD; red in 
overlay). B: collagen II (green in overlay). C: DAPI (blue in overlay). D: Overlay. 
Magnification: 400x 
 
Figure 5: Influence of growth factors on the differentiation by immunostaining of the 
putative NP-specific marker protein cytokeratin 19 (Krt 19) on days 1, 4, 7, 11, 15 and 
21. A: Krt 19 (red in overlay). B: DAPI (blue in overlay). C: Overlay. Magnification: 
2,100x (630x optical and 3 1/3x digital) 
 
Figure 6: Immunostaining of the putative NP-specific marker protein cytokeratin 19 
(Krt 19) on NP cells cultivated for 23 days in a hydrogel to sustain the differentiation 
status. A: Krt 19 (red in overlay). B: DAPI (blue in overlay). C: Overlay. Magnification: 
2,100x (630x optical and 3 1/3x digital) 
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